Research Paper Volume 15, Issue 13 pp 6302—6330
Clinical significance, tumor immune landscape and immunotherapy responses of ADAR in pan-cancer and its association with proliferation and metastasis of bladder cancer
Figure 6. Potential functions and molecular pathways of ADAR in BLCA. (A) Differential analysis between the ADAR high-expression group and the ADAR low-expression group. (B) High ADAR expression predicts a higher frequency of gene mutations. (C, D) GO and KEGG enrichment analysis of differentially expressed genes.